中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 12
Dec.  2016
Turn off MathJax
Article Contents

Clinical types and features of chronicity of drug-induced liver injury

DOI: 10.3969/j.issn.1001-5256.2016.12.025
Research funding:

 

  • Published Date: 2016-12-20
  • Objective To investigate the clinical types and features of chronicity of drug- induced liver injury( DILI). Methods The patients who were diagnosed with DILI in Beijing You An Hospital,Capital Medical University from January 2011 to December 2013 were screened,and a retrospective analysis was performed for 84 patients with chronic DILI. The case report form was filled out for each patient,and the data were entered into a database,including demographic features,underlying diseases,types of drugs,cardinal symptoms and signs,and laboratory examinations. Results Of all patients,63( 75. 0%) were female. The chronicity of DILI could be divided into six clinical types according to disease progression and recovery of liver function; of all patients,64( 76. 2%) had a recurrent type,4( 4. 8%)had a delayed recovery type,4( 4. 8%) had a recurrent fluctuation type,6( 7. 1%) had a chronic cholestasis type,5( 6. 0%) had a type of rapid progression to liver cirrhosis,and 1( 1. 2%) had a type of drug- induced autoimmune hepatitis. Among all the 84 patients,56( 66. 7%) had underlying diseases; 51( 60. 7%) had DILI induced by a single drug,mainly traditional Chinese medicine( 47. 0%),antipyretics and analgesics( 10. 6%),and antitubercular agents( 9. 1%); as for the type of liver injury,52( 61. 9%) had hepatocyte injury,8( 9. 5%) had cholestasis,and 5( 6. 0%) had a mixed type. Liver biochemistries showed abnormal results in 19 patients( 22. 6%). Conclusion The chronicity of DILI can be divided into six clinical types,of which the most common type is the recurrent type,and the other clinical types include delayed recovery type,recurrent fluctuation type,chronic cholestasis type,rapid progression to liver cirrhosis,and drug- induced autoimmune hepatitis.

     

  • loading
  • [1]Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
    [2]DANAN G,TESCHKE R.RUCAM in drug and herb induced liver injury:the update[J].Int J Mol Sci,2015,17(1).pii:e14.
    [3] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association.Consensus on the diagnosis and treatment of cholestasis liver diseases(2015)[J].J Clin Hepatol,2015,31(12):1989-1999.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.胆汁淤积性肝病诊断和治疗共识(2015)[J].临床肝胆病杂志,2015,31(12):1989-1999.
    [4]HAYASHI PH,FONTANA RJ.Clinical features,diagnosis and natural history of drug-induced liver injury[J].Semin Liver Dis,2014,34(2):134-144.
    [5]BJRNSSON E,TALWALKAR J,TREEPRASERTSUK S,et al.Drug induced autoimmune hepatitis:clinical characteristics and prognosis[J].Hepatology,2010,51(6):2040-2048.
    [6]CASTIELLA A,LUCENA MI,ZAPATA EM,et al.Drug-induced autoimmune-like hepatitis:a diagnostic challenge[J].Dig Dis Sci,2011,56(8):2501-252.
    [7]ANDRADE RJ,LUCENA MI,KAPLOWITZ N,et al.Outcome of acute idiosyncratic drug-induced liver injury:long-term follow-up in a hepatotoxicity registry[J].Hepatology,2006,44(6):1581-1588.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2116) PDF downloads(465) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return